Browse > Article
http://dx.doi.org/10.15324/kjcls.2020.52.4.342

Comparative Analysis of Uropathogenic Escherichia coli ST131 and Non-ST131 Isolated from Urinary Tract Infection Patients in Daejeon  

Cho, Hye Hyun (Departments of Biomedical Laboratory Science, Daejeon Institute of Science and Technology)
Publication Information
Korean Journal of Clinical Laboratory Science / v.52, no.4, 2020 , pp. 342-348 More about this Journal
Abstract
Uropathogenic Escherichia coli (UPEC) is a major cause of urinary tract infections (UTIs), which is one of the most common infectious diseases in humans worldwide. Since UPEC is increasingly gaining resistance to many antimicrobial agents, antibiotic therapy of UTI has recently become a great concern. This study examined the epidemiological relationship, and antimicrobial resistance patterns of 84 UPEC isolates obtained from UTI patients in Daejeon, from March to December 2017. Molecular epidemiology was investigated by multilocus sequence typing (MLST), and an antimicrobial susceptibility test was determined using an E-test. In this study, UTI was more common in females (73.8%) than in males (26.2%), and the highest incidence of UTI was observed in the age group in their 70s. Among the 84 UPEC isolates, 59 isolates (70.2%) were multidrug-resistant (MDR), and the major sequence type was ST131 (44 isolates, 52.4%). Interestingly, the rates of MDR in non-ST131 isolates (72.5%) were higher compared to ST131 isolates (68.2%). These results indicate the possibility of the development and spread of MDR in non-ST131 isolates. Effective surveillance networks and continuous research need to be conducted globally to prevent the emergence and international spread of MDR non-ST131 isolates.
Keywords
MDR; Non-ST131; UPEC;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Dadi BR, Abebe T, Zhang L, Mihret A, Abebe W, Amogne W. Distribution of virulence genes and phylogenetics of uropathogenic Escherichia coli among urinary tract infection patients in Addis Ababa, Ethiopia. BMC Infect Dis. 2020;20:108. https://doi.org/10.1186/s12879-020-4844-z   DOI
2 Foxman B. The epidemiology of urinary tract infection. Nat Rev Urol. 2010;7:653-660. https://doi.org/10.1038/nrurol.2010.190   DOI
3 Hooton TM. Recurrent urinary tract infection in women. Int J Antimicrob Agents. 2001;17:259-268. https://doi.org/10.1016/s0924-8579(00)00350-2   DOI
4 Foxman B. Recurring urinary tract infection: incidence and risk factors. Am J Public Health. 1990;80:331-333. https://doi.org/10.2105/ajph.80.3.331   DOI
5 Norouzian H, Katouli M, Shahrokhi N, Sabeti S, Pooya M, Bouzari S. The relationship between phylogenetic groups and antibiotic susceptibility patterns of Escherichia coli strains isolated from feces and urine of patients with acute or recurrent urinary tract infection. Iran J Microbiol. 2019;11:478-487.
6 Loh K, Sivalingam N. Urinary tract infections in pregnancy. Malays Fam Physician. 2007;2:54-57.
7 Schwartz DJ1, Kalas V, Pinkner JS, Chen SL, Spaulding CN, Dodson KW, et al. Positively selected FimH residues enhance virulence during urinary tract infection by altering FimH conformation. Proc Natl Acad Sci U S A. 2013;110:15530-15537. https://doi.org/10.1073/pnas.1315203110   DOI
8 Ronald A. The etiology of urinary tract infection: traditional and emerging pathogens. Am J Med. 2002;113:14S-19S. https://doi.org/10.1016/s0002-9343(02)01055-0   DOI
9 Zowawi HM, Harris PN, Roberts MJ, Tambyah PA, Schembri MA, Pezzani MD, et al. The emerging threat of multidrug-resistant Gram-negative bacteria in urology. Nat Rev Urol. 2015;12:570-584. https://doi.org/10.1038/nrurol.2015.199   DOI
10 Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18:268-281. https://doi.org/10.1111/j.1469-0691.2011.03570.x   DOI
11 Alghoribi MF, Gibreel TM, Farnham G, Al Johani SM, Balkhy HH, Upton M. Antibiotic-resistant ST38, ST131 and ST405 strains are the leading uropathogenic Escherichia coli clones in Riyadh, Saudi Arabia. J Antimicrob Chemother. 2015;70:2757-2762. https://doi.org/10.1093/jac/dkv188   DOI
12 Nicolas-Chanoine MH, Bertrand X, Madec JY. Escherichia coli ST131, an intriguing clonal group. Clin Microbiol Rev. 2014;27:543-574. https://doi.org/10.1128/CMR.00125-13   DOI
13 Nicolas-Chanoine MH, Blanco J, Leflon-Guibout V, Demarty R, Alonso MP, Canica MM, et al. Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15. J Antimicrob Chemother. 2008;61:273-281. https://doi.org/10.1093/jac/dkm464   DOI
14 Peirano G, Pitout JD. Molecular epidemiology of Escherichia coli producing CTX-M beta-lactamases: the worldwide emergence of clone ST131 O25:H4. Int J Antimicrob Agents. 2010;35:316-321. https://doi.org/10.1016/j.ijantimicag.2009.11.003   DOI
15 Alqasim A, Abu Jaffal A, Alyousef AA. Prevalence and molecular characteristics of sequence type 131 clone among clinical uropathogenic Escherichia coli isolates in Riyadh, Saudi Arabia. Saudi J Biol Sci. 2020;27:296-302. https://doi.org/10.1016/j.sjbs.2019.09.020   DOI
16 Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; twentieth informational supplement, M100-S20. Wayne, PA: Clinical and Laboratory Standards Institute; 2010.
17 Cheung DA, Nicholson A, Butterfield TR, da Costa M. Prevalence, co-infection and antibiotic resistance of Escherichia Coli from blood and urine samples at a hospital in Jamaica. J Infect Dev Ctries. 2020;14:146-152. https://doi.org/10.3855/jidc.11361   DOI
18 Mortazavi-Tabatabaei SAR, Ghaderkhani J, Nazari A, Sayehmiri K, Sayehmiri F, Pakzad I. Pattern of antibacterial resistance in urinary tract infections: A systematic review and meta-analysis. Int J Prev Med. 2019;10:169. https://doi.org/10.4103/ijpvm.IJPVM_419_17   DOI
19 Kothari A, Sagar V. Antibiotic resistance in pathogens causing community-acquired urinary tract infections in India: A multicenter study. J Infect Dev Ctries. 2008;2:354-358. https://doi.org/10.3855/jidc.196   DOI
20 Matsui Y, Hu Y, Rubin J, de Assis RS, Suh J, Riley LW. Multilocus sequence typing of Escherichia coli isolates from urinary tract infection patients and from fecal samples of healthy subjects in a college community. Microbiologyopen. 2020;9:e1032. https://doi.org/10.1002/mbo3.1032   DOI
21 Goncalves LF, de Oliveira Martins-Júnior P, de Melo ABF, da Silva RCRM, de Paulo Martins V, Pitondo-Silva A, et al. Multidrug resistance dissemination by extended-spectrum β-lactamase-producing Escherichia coli causing community-acquired urinary tract infection in the Central-Western Region, Brazil. J Glob Antimicrob Resist. 2016;6:1-4. https://doi.org/10.1016/j.jgar.2016.02.003   DOI
22 da Cruz Campos AC, Cavallo FM, L Andrade N, van Dijl JM, Couto N, Zrimec J, et al. Determining the virulence properties of Escherichia coli ST131 containing bacteriocin-encoding plasmids using short- and long-read sequencing and comparing them with those of other E. coli lineages. Microorganisms. 2019;7:E534. https://doi.org/10.3390/microorganisms7110534   DOI
23 Wu J, Lan F, Lu Y, He Q, Li B. Molecular characteristics of ST1193 clone among phylogenetic group B2 non-ST131 fluoroquinolone-resistant Escherichia coli. Front Microbiol. 2017;8:2294. https://doi.org/10.3389/fmicb.2017.02294   DOI
24 Manges AR, Johnson JR, Foxman B, O'Bryan TT, Fullerton KE, Riley LW. Widespread distribution of urinary tract infections caused by a multidrug-resistant Escherichia coli clonal group. N Engl J Med. 2001;345:1007-1013. https://doi.org/10.1056/NEJMoa011265   DOI
25 Kim B, Seo MR, Kim J, Kim Y, Wie SH, Ki M, et al. Molecular epidemiology of ciprofloxacin-resistant Escherichia coli isolated from community-acquired urinary tract infections in Korea. Infect Chemother. 2020;52:194-203. https://doi.org/10.3947/ic.2020.52.2.194   DOI
26 Mukherjee M, Basu S, Mukherjee SK, Majumder M. Multidrug-resistance and extended spectrum beta-lactamase production in uropathogenic E. Coli which were isolated from hospitalized patients in Kolkata, India. J Clin Diagn Res. 2013;7:449-453. https://doi.org/10.7860/JCDR/2013/4990.2796   DOI
27 Iranpour D, Hassanpour M, Ansari H, Tajbakhsh S, Khamisipour G, Najafi A. Phylogenetic groups of Escherichia coli strains from patients with urinary tract infection in Iran based on the new clermont phylotyping method. Biomed Res Int. 2015;2015:846219. https://doi.org/10.1155/2015/846219   DOI
28 Plantamura J, Bousquet A, Vedy S, Larreche S, Bigaillon C, Delacour H, et al. Molecular epidemiological of extended-spectrum β-lactamase producing Escherichia coli isolated in Djibouti. Infect Dev Ctries. 2019;13:753-758. https://doi.org/10.3855/jidc.11283   DOI